Nutriband (NTRB) Osake Kurssi
Nutriband Kurssi
Liikevaihto on kasvanut 35,3 % vuodessa viimeisten 7 vuoden aikana 2,04 M USD:een. Nutribandn nettomarginaali on nyt −404,1 %, noussut −592,2 %:sta muutama vuosi sitten. Analyytikoiden mediaanitavoitehinta on 15,30 USD, eli yli nykyhintaa 126,7 %. 7 analyytikosta 6 suosittaa ostoa — kokonaiskonsensus on Osta.
Nutriband osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
Nutriband liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Nutriband -osakkeesta
The business model of Nutriband Inc revolves around developing and marketing innovative transdermal patches that deliver essential nutrients, vitamins, and other beneficial substances to the body. Nutriband specializes in creating patches that offer an alternative delivery system for various health and wellness products. By leveraging advanced technology and research, Nutriband aims to provide consumers with convenient and effective solutions to address their nutritional needs. The company focuses on creating partnerships with manufacturers, distributors, and retailers to scale its business globally. Nutriband Inc continuously strives to enhance its product formulations and expand its range to cater to a wide range of health-conscious individuals.
Nutriband Inc is primarily active in the health and wellness industry.
The main competitors of Nutriband Inc in the market are companies like Herbalife Nutrition Ltd, Pfizer Inc, GlaxoSmithKline PLC, and Johnson & Johnson.
Nutriband Inc is a global company specializing in the development and commercialization of advanced transdermal drug delivery systems. Founded in 2010, Nutriband has established itself as a leader in the industry through its innovative and effective medical patch technology. The company focuses on developing products that enhance patient care and convenience, offering pharmaceutical, over-the-counter, and cannabis-infused patches. Nutriband Inc has successfully launched a range of products and is committed to continued research and development to provide cutting-edge solutions in the healthcare sector. With its expertise and dedication, Nutriband Inc has become a trusted name in the field of transdermal drug delivery.
Nutriband Inc has achieved several significant milestones. The company successfully launched its flagship product line, utilizing innovative transdermal patch technology for efficient nutrient delivery. Nutriband Inc also expanded its distribution channels, securing partnerships with major retailers and expanding its global market reach. Additionally, the company attained regulatory approvals for its products, ensuring compliance and safety. Nutriband Inc has demonstrated consistent growth, driven by its dedication to research and development, customer satisfaction, and commitment to delivering high-quality, effective nutritional solutions. These milestones reflect Nutriband Inc's ongoing success and position in the market as a trusted provider of innovative and effective health products.
Nutriband Inc is primarily present in multiple countries and regions across the globe. The company has a global presence, including but not limited to the United States, Europe, Asia, and South America. With its headquarters located in Orlando, Florida, Nutriband Inc has successfully expanded its operations and market reach to cater to a diverse customer base. As a reputable player in the industry, Nutriband Inc continues to grow its international presence through strategic partnerships and distribution networks, ensuring its products and innovations are accessible to consumers worldwide.
Nutriband Inc represents a strong commitment to promoting health and wellness through its innovative products. With a focus on providing effective and convenient solutions, Nutriband Inc offers a range of transdermal patches that deliver essential nutrients and supplements. The company's philosophy centers around the belief that everyone deserves access to high-quality and science-backed wellness solutions. By combining cutting-edge technology with a dedication to research and development, Nutriband Inc strives to help individuals achieve optimal health and well-being. With a growing presence in the market, Nutriband Inc continues to prioritize customer satisfaction and transparency, ensuring the highest level of integrity in all its operations.
Analyytikot asettavat tällä hetkellä Nutriband-osakkeelle keskimääräisen tavoitehinnan 15,30 USD (mediaani: 15,30 USD), mikä merkitsee +126,7 % viimeisimpään hintaan verrattuna. Konsensus perustuu 7 analyytikkoarvioon.
7 analyytikkoa arvioi tällä hetkellä Nutriband-osaketta: 6 suosittaa ostoa, 1 pitoa ja 0 myyntiä.
Nykyisellä valuuttakurssilla Nutriband-osake noteerataan hintaan 6,00 EUR (6,75 USD).
Nutriband-osake (NTRB) on listattuna 2 pörssissä, muun muassa: NASDAQ (NTRB), Frankfurt (9WV.F).
Nutriband Inc is an American company that specializes in the manufacturing and distribution of transdermal patch products. The company is headquartered in Orlando, Florida, and was founded in 2010. Nutriband's business model is based on innovative transdermal patch technologies that allow customers to absorb nutrients, medications, and other active ingredients directly through the skin. The products are easy to use and offer a variety of advantages over traditional oral medications. Nutriband has a wide range of products tailored to different customer needs, including supplements, pain therapy, medication delivery, and wellness. The company has a strong distribution channel that enables global sales, including partnerships with various distributors and online platforms like Amazon. Overall, Nutriband has a robust business model based on innovative transdermal patch products and works with strong distribution partners to support product sales.
liikevaihto Nutriband on 2,04 M USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
voitto Nutriband on −8,23 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Nutriband:n hinta-voitto-suhde (P/E) on tällä hetkellä −9,97. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Nutriband-osakkeen arvostusta.
Nutriband:n hinta-myynti-suhde (P/S) on tällä hetkellä 40,29. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Nutriband-osakkeen arvostuskennuslukuna.
Nutriband:n Eulpool-laatuscore on 3/10.
Nutriband:n ISIN on US67092M2089. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Nutriband:n WKN on A3C484. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Nutriband:n ticker on NTRB. Tämä pörssinoteeraus käytetään Nutriband-osakkeiden kauppaan pörssissä.
Nutriband osake
Nutriband vertaisryhmä
Nutriband Ticker
Nutriband FIGI
Kaikki tunnusluvut ja syvällinen analyysi Nutriband:sta
Meidän osakeanalyysimme Nutriband-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Nutriband:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: